CPC-211 small molecule inhibitor of lactate accumulation: Began a Phase II dose-ranging trial of single, intravenous doses. Blood and cerebrospinal fluid levels

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-211 small molecule inhibitor of lactate accumulation Indication: Closed head injury Status: Began a Phase II dose-ranging trial of sin...